Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Lymphoma 272Lymphoma, Large B-Cell, Diffuse 259Leukemia, Lymphocytic, Chronic, B-Cell 189Lymphoma, Non-Hodgkin 187Lymphoma, Mantle-Cell 165Lymphoma, Follicular 164Lymphoma, B-Cell, Marginal Zone 115Leukemia 94Burkitt Lymphoma 82Precursor Cell Lymphoblastic Leukemia-Lymphoma 79Waldenstrom Macroglobulinemia 77Lymphoma, B-Cell 62Recurrence 51Hodgkin Disease 50Lymphoma, Large-Cell, Immunoblastic 44Lymphoma, Large-Cell, Anaplastic 20Leukemia, Myeloid, Acute 20Myelodysplastic Syndromes 18Intraocular Lymphoma 15Hematologic Neoplasms 15Neoplasms 14Dendritic Cell Sarcoma, Interdigitating 14Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 13Multiple Myeloma 13Leukemia, Hairy Cell 13Leukemia, Myelogenous, Chronic, BCR-ABL Positive 11Neoplasms, Plasma Cell 10Leukemia, Prolymphocytic 10Lymphoma, T-Cell 9Leukemia, Myelomonocytic, Chronic 9

Interventions

Temozolomide 2Granulocyte Colony-Stimulating Factor 2Filgrastim 2Cyclophosphamide 2venetoclax 1trametinib 1toripalimab 1sonidegib 1ribociclib 1fludarabine 1etoposide phosphate 1camrelizumab 1apatinib 1acalabrutinib 1Vincristine 1Thiotepa 1Therapeutics 1Telemedicine 1Tamoxifen 1Standard of Care 1Rituximab 1Radiotherapy 1R-CHOP protocol 1Patient Navigation 1Mesna 1Isotretinoin 1Interviews as Topic 1Immunotherapy, Adoptive 1Hydrocortisone 1Genetic Testing 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Pyloric Stenosis, Hypertrophic × Rituximab × Clear all
NCT04058470 2022-04-14

Toripalimab Plus Rituximab Followed by R-CHOP for Elderly Patients With Untreated Diffused B Cell Lymphoma

Sun Yat-sen University

Phase 1/2 Unknown
140 enrolled
Lymphoid

Lymphoma, Large B-Cell, Diffuse, Pyloric Stenosis, Hypertrophic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡